Copyright
©The Author(s) 2018.
World J Clin Cases. Sep 26, 2018; 6(10): 322-334
Published online Sep 26, 2018. doi: 10.12998/wjcc.v6.i10.322
Published online Sep 26, 2018. doi: 10.12998/wjcc.v6.i10.322
Table 1 Geographical distribution of published cases affected with Laugier-Hunziker syndrome
| Country | No. of cases | Percentage (%) | Ref. | |
| 1 | France | 59 | 29 | [1,14,20-22,24,26,27,30,31] |
| 2 | Italy | 33 | 16 | [11,12,18,25,28,29,33,34-37,40,63] |
| 3 | China | 30 | 14.5 | [5,9,10,19,23,58,72] |
| 4 | United States | 14 | 7 | [13,16,32,42,46,51,60,67-69,73,77,85,88] |
| 5 | United Kingdom | 13 | 6 | [3,39,45,49,52,54,76] |
| 6 | Germany | 12 | 6 | [40,61] |
| 7 | India | 8 | 4 | [47,56,57,70,71,81,86] |
| 8 | Turkey | 6 | 3 | [7,50,53,62,75,83] |
| 9 | Greece | 5 | 2 | [6,40,48] |
| 10 | Japan | 5 | 2 | [8,44,55,59] |
| 11 | Lebanon | 3 | 1.5 | [17] |
| 12 | Portugal | 2 | 1 | [23,43] |
| 13 | Brazil | 2 | 1 | [65,78] |
| 14 | Spain | 2 | 1 | [66] |
| 15 | Australia | 2 | 1 | [87] |
| 16 | Finland | 1 | 0.5 | [4] |
| 17 | Ireland | 1 | 0.5 | [15] |
| 18 | Russia | 1 | 0.5 | [38] |
| 19 | Switzerland | 1 | 0.5 | [41] |
| 20 | South Korea | 1 | 0.5 | [64] |
| 21 | Austria | 1 | 0.5 | [74] |
| 22 | Serbia | 1 | 0.5 | [79] |
| 23 | Chile | 1 | 0.5 | [80] |
| 24 | Romania | 1 | 0.5 | [82] |
| 25 | Singapore | 1 | 0.5 | [84] |
Table 2 Distribution of involved locations of pigmentary lesions in Laugier-Hunziker syndrome
| Involved locations | Frequency | Ref. | |
| Lip | 75% (154/206) | [1,3-16,18,19,21-25,27-29,31-38,40,41,43-52,54-68,70-73,75-78,80,83,85-88] | |
| Oral cavity | 68% (140/206) | [1,3-9,11-19,21-24,26,27,29,31-33,35-44,46,47,50-60,62-76,78,79,81,82,84-88] | |
| Acral area | Nail | 47% (96/206) | [1,3-10,12,14-17,19,22,23,25-27,31,32,34,39-41,43,44,47,49,50,52-54,56-59,61,63-66,68-72,77-84,86] |
| Periungual area | 8% (17/206) | [8,14,16,25,31,34,43,47,50,54,64,65,71,73,77,79,81] | |
| Finger | 13% (26/206) | [5,8,9,11,14,19,21,41,43,49,55-57,59,60,66,70-72,74,76,84-86,88] | |
| Palm | 4% (8/206) | [7,43,44,46,59,60,62,81] | |
| Toes | 3% (6/206) | [19,56,59,70,84,86] | |
| Sole | 3% (6/206) | [7,21,46,59,62] | |
| Genitalia | Penis | 24% (17/70)1 | [20-23,46] |
| Vulva or labia majora | 10% (13/127)1 | [7,12,15,17,21,30,58,74] | |
| Anal mucosa and perianal area | 1.5% (3/206) | [21,41] | |
| Conjunctiva and sclera | 4% (9/206) | [6,7,17,19,23,46,60,83] | |
| Eyebrow and periorbital area | 1.5% (3/206) | [41,53,71] | |
| Pharynx | 0.5% (1/206) | [4] | |
| Esophagus | 0.5% (1/206) | [44] | |
| Neck, thorax, and abdomen | 1% (2/206) | [25,81] | |
| Back | 0.5% (1/206) | [50] | |
| Elbow | 1% (2/206) | [43,76] | |
| Pretibial area | 0.5% (1/206) | [62] | |
Table 3 Various conditions associated with labial or oral pigmentation
| Focal | Diffuse | |
| Exogenous origin | Amalgam tattoo | Tobacco-associated melanin pigmentation |
| (smoker’s melanosis) | ||
| Topical medications | Drugs (e.g., antimalarials, tetracyclines, ketoconazole, zidovudine, phenothiazines, oral contraceptives, and chemotherapeutic agents) | |
| Graphite tattoo (e.g., carbon, lead pencils) | Heavy metals (including bismuth, mercury, silver, lead, gold, arsenic, tin, copper, brass, zinc, cadmium, chrome, and manganese) | |
| Endogenous origin | Melanotic macule | Physiologic (racial) pigmentation |
| Melanocytic nevus | Posttraumatic or postinflammatory pigmentation | |
| Melanoacanthoma | Lichen planus | |
| Melanoma | Discoid lupus erythematosus | |
| Hemangioma | LHS | |
| Lentigo maligna | Peutz-Jeghers syndrome | |
| Kaposi sarcoma | Addison’s disease | |
| McCune-Albright syndrome | ||
| Neurofibromatosis type 1 (von Recklinghausen’s disease) | ||
| Carney complex (NAME/LAMB syndrome) | ||
| LEOPARD syndrome (lentiginosis profusa syndrome) | ||
| Cronkhite-Canada syndrome | ||
| Cushing syndrome | ||
| Incontinentia pigmenti syndrome (Bloch-Sulzberger syndrome) | ||
| Acanthosis nigricans | ||
| Dyschromatosis symmetrica hereditaria | ||
| Tuberous sclerosis | ||
| Xeroderma pigmentosum | ||
| Dyskeratosis congenita | ||
| Hemochromatosis | ||
| Fanconi anemia |
Table 4 Differential diagnosis between Peutz-Jeghers syndrome and Laugier-Hunziker syndrome
| PJS | LHS | |
| Inheritance | Autosomal dominant (STK11 gene) | Sporadic and acquired |
| Age of onset | Birth to infancy | Adult onset |
| Shape of mucocutaneous pigmented macules | Freckle-like | Lenticular |
| Labial pigmentation | Very common | Very common |
| Oral pigmentation | Common | Very common |
| Perioral, perirhinal, or periorbital pigmentation | Common | Uncommon |
| Nail pigmentation | Uncommon | Very common |
| Acral skin pigmentation | Common | Common |
| Systemic involvement | Gastrointestinal polyposis | None |
| Risk of malignancy | Colon, gastric, small intestinal, pancreatic, breast, ovarian, thyroid, lung, and Sertoli cell (in men) cancers | None |
Table 5 Differential diagnosis of nail pigmentation
| Causation of nail pigmentation | Condition | |
| Nonmelanocytic origin | Exogenous | Dirt |
| Tobacco | ||
| Tar | ||
| Potassium hypermanganate | ||
| Silver nitrate | ||
| Infectious | Bacterial infection | |
| (e.g., Pseudomonas aeruginosa) | ||
| Onychomycosis | ||
| (fungal infection) | ||
| Traumatic | Subungual hemorrhage | |
| Subungual hematoma | ||
| Neoplastic | Hemangioma | |
| Melanocytic origin | Physiological | Ethnic (racial) melanonychia |
| Nutritional | Vitamin B12 deficiency | |
| Traumatic | Onychotillomania (nail biting) | |
| Frictional melanonychia | ||
| Iatrogenic | Systemic drug-induced melanonychia | |
| (e.g., zidovudine, hydroxyurea, and minocyline) | ||
| Radiotherapy-induced melanonychia | ||
| Inflammatory | Lichen planus | |
| Psoriasis | ||
| Endocrinic | Addison’s disease | |
| Pregnancy | ||
| Syndromic | LHS | |
| AIDS | ||
| Activated melanocytic | Benign melanocytic hyperplasia | |
| Lentigo simplex | ||
| Nevus | ||
| Neoplastic | Onychopapilloma | |
| Onychomatricoma | ||
| Bowen’s disease | ||
| Melanoma | ||
- Citation: Duan N, Zhang YH, Wang WM, Wang X. Mystery behind labial and oral melanotic macules: Clinical, dermoscopic and pathological aspects of Laugier-Hunziker syndrome. World J Clin Cases 2018; 6(10): 322-334
- URL: https://www.wjgnet.com/2307-8960/full/v6/i10/322.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v6.i10.322
